Niacinamide for the treatment of melasma: an integrative review of randomized clinical trials




Melasma; Niacinamide; Skin pigmentation; Quality of life.


Introduction: Melasma is a very common and difficult to treat hypermelanosis because it usually responds poorly to therapies, negatively affecting the quality of life of patients. Objective: to know and analyze the scientific evidence related to the treatment of patients with facial melasma treated with niacinamide.  Method: a literature review was performed based on a data search in BIREME, PubMed, SciELO and ScienceDirect. Articles indexed in these electronic journals were included in the time frame from 2011 to 2019. Results: Evidence analyzes revealed a major impact on the appearance of facial melasma after niacinamide treatment. Well, the studies (100%) concluded improvement of the spots with the treatment time, improving the appearance of the skin. Conclusion: Evidence shows that niacinamide has a lightening property in adult women with improvement of melanic hyperpigmentation caused by melasma. However, there is very little evidence published in the last decade using pure niacinamide for increased pigmentation in melasma.


Abdel-Naser, M. B., Seltmann, H., & Zouboulis, C. C. (2012). SZ95 sebocytes induce epidermal melanocyte dendricity and proliferation in vitro. Experimental Dermatology, 21(5), 393-395.

Babbush, K. M. Babbush, R. A., & Khachemoune, A. (2020). The Therapeutic Use of Antioxidants for Melasma. Journal of Drugs in Dermatology, 19(8), 788-792.

Briganti, D., Flori, E., Mastrofrancesco, A., Kovacs, D., Camera, E., Ludovici, M., Cardinali, G., & Picardo, M. (2013). Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ. Experimental Dermatology, 22(1), 41-47, 2013.

Brazilian Society of Dermatology. (2006). Perfil nosológico das consultas dermatológicas no Brasil. Anais Brasileiros de Dermatologia, 81(6), 549-558.

Campuzano-García, A. E., Torres-Alvarez, B., Hernández-Blanco, D., Fuentes-Ahumada, C., Cortés-García, J. D., & Castanedo-Cázares, J. P. (2019). DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo. BioMed Research International, 1, 9068314.

Cestari, T. F., Hexsel, D., Viegas, M. L., Azulay, L., Hassun, K., Almeida, A. R. T., Rêgo, V. R. P. A., Mendes, A. M. D., Filho, J. W. A., & Junqueira, H. (2006). Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. The British Journal of Dermatology, 156(1), 13-20.

Cosmetic Ingredient Review Expert Panel. (2005). Final report of the safety assessment of niacinamide and niacin. International Journal of Toxicology, 24(5), 1-31.

Giansante, E., Merchpan-Pérez, E., & Poleo-Brito, L. (2020). Melasma treatment: comparative study between triple combination vs topical niacinamide and triple combination vs tranexamic intradermal acid. Journal of the Dermatology Nurse’s Association, 12(2), 1-1.

Jiang, J., Akinseye, O., Tovar-Garza, A., & Pandya, A. G. (2017). The effect of melasma on self-esteem: A pilot study. Internation Journal of Women’s Dermatology, 4(1), 38-42.

Kang, W. H., Yoon, K. H., Lee, E. S., Kim, J., Lee, K. B., Yim, H., Sohn, S., & Im, S. (2002). Melasma: histopathological characteristics in 56 Korean patients. The British Journal of Dermatology, 146(2), 228-237.

Kang, H. Y., Suzuki, I., Lee, D. J., Ha, J., Reiniche, P., Aubert, J., Deret, S., Zugaj, D., Voegel, J. J., & Ortonne, J. P. (2011). Transcriptional Profiling Shows Altered Expression of Wnt Pathway- and Lipid Metabolism-Related Genes as Well as Melanogenesis-Related Genes in Melasma. Journal of Investigative Dermatology, 131(8), 1692-700.

Kim, J. Y., Lee, T. R., & Lee, A. Y. (2013). Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma. Journal of Investigative Dermatology, 133(1), 191-200.

Kwon, S. H., Hwang, Y. J., Lee, S. K., & Park, K. C. (2016). Heterogeneous Pathology of Melasma and Its Clinical Implications. International Journal of Molecular Sciences, 17(6), 824, 2016.

Kwon, S. H., Na, J. I., Choi, J. Y., & Park, K. C. (2019). Melasma: Updates and perspectives. Experimental Dermatology, 28(6), 704-708.

Kuthial, M., Kaur, T., Malhota, S. K., & Gujral, U. (2019). Estimation of serum copper, superoxide dismutase and reduced glutathione levels in melasma: a case control study. Internationl Journal of Scientific Research, 8(5), 25-27.

Lee, D. J., Park, K. C., Ortonne, J. P., & Kang, H. Y. (2012). Pendulous melanocytes: a characteristic feature of melasma and how it may occur. The British Journal of Dermatology, 166(3), 684-686.

Lee, A. Y. (2015). Recent progress in melasma pathogenesis. Pigment Cell & Melanona Research, 28(6), 648-660.

Lee, M. H., Lee, K. K., Park, M. H., Hyun, S. S., Kahn, S. Y., Joo, K. S., Kang, H. C., & Kwon, W. T. (2016). In vivo anti-melanogenesis activity and in vitro skin permeability of niacinamide-loaded flexible liposomes (Bounsphere™). Journal of Drug Delivery Science and Technology, 31(1), 147-152.

Madaan, P., Sikka, P., & Malik, D, S. (2021). Cosmeceutical Aptitudes of Niacinamide: A Review. Recent Advances in Anti-Infective Drug Discovery, 16(3), 196-208.

Navarrete-Solís, J., Castanedo-Cázares, J. P., Torres-Álvarez, B., Oros-Ovalle, C., Fuentes-Ahumada, C., González, F. J., Martínez-Ramírez, J. D., & Moncada, B. (2011). A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma. Dermatology Research and Practice, 1(1), 1-5.

Ogbechie-Godec, O. A., & Elbuluk, N. (2017). Melasma: an Up-to-Date Comprehensive Review. Dermatology and Therapy, 7(3), 305-318.

Passeron, T. (2013). Melasma pathogenesis and influencing factors - an overview of the latest research. Journal of the European Academy of Dermatology and Venereology, 17(1), 5-6.

Passeron, T., & Picardo, M. (2018). Melasma, a photoaging disorder. Pigment Cell & Melanoma Research, 31(4), 461-465.

Picardo, M., Zompetta, C., De Luca, C., Cirone, M., Faggioni, A., Nazzaro-Porro, M., Passi, S., & Prota, G. (1991). Role of skin surface lipids in UV-induced epidermal cell changes. Archives of Dermatological Research, 283(3), 191-197.

Pollo, C. F., Meneguin, S., & Miot, H. A. (2018). Evaluation Instruments for Quality of Life Related to Melasma: An Integrative Review. Clinics, 73(1), e65.

Santos-Caetano, J. P., Gfeller, C. F., Mahalingam, H., Thompson, M., Moore, D. J., Vila, R., Doi, R., & Cargill, M. R. (2020). Cosmetic benefits of a novel biomimetic lamellar formulation containing niacinamide in healthy females with oily, blemish-prone skin in a randomized proof-of-concept study. International Journal of Cosmetic Science, 42(1), 29-35.

Sarkar, R., Bansal, A., & AilawadI, P. (2020). Future therapies in melasma: What lies ahead?. Indian Journal of Dermatology, Venereology and Leprology, 86(1), 8-17.

Sheth, V. M., & Pandya, A. G. (2011). Melasma: a comprehensive update: part II. Journal of the American Academy of Dermatology, 65(4), 699-714.

Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, 104(1), 333-339.

Vashi, N. A., & Kundu, R. V. (2013). Facial hyperpigmentation: causes and treatment. The British Journal of Dermatology, 169(3),

Wohlrab, J., & Kreft, D. (2014). Niacinamide - Mechanisms of Action and Its Topical Use in Dermatology. Skin Pharmacology and Physiology, 27(6), 311-315.

Yuan, X. H., & Jin, Z. H. (2018). Paracrine regulation of melanogenesis. The British Journal of Dermatology, 178(3), 632-639.

Zeng, X., Qiu, Y., & Xiang, W. (2020). In vivo reflectance confocal microscopy for evaluating common facial hyperpigmentation. Skin Research and Technology, 26(2), 215-219.




How to Cite

PEDROSO, A. G. .; FURTADO, G. R. D. .; BARBOSA, K. L. . Niacinamide for the treatment of melasma: an integrative review of randomized clinical trials. Research, Society and Development, [S. l.], v. 11, n. 11, p. e198111133581, 2022. DOI: 10.33448/rsd-v11i11.33581. Disponível em: Acesso em: 25 feb. 2024.



Health Sciences